Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_assertion type Assertion NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_head.
- NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_provenance.
- NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_assertion evidence source_evidence_literature NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_provenance.
- NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_assertion SIO_000772 19434073 NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_provenance.
- NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_assertion wasDerivedFrom gad-20150221 NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_provenance.
- NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_assertion wasGeneratedBy ECO_0000203 NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_provenance.